共 157 条
- [11] Clarke R(2019)High lipoprotein(a) and high risk of mortality Eur Heart J 40 2760-70
- [12] Peden JF(2022)Association of lipoprotein(a) with all-cause and cause-specific mortality: A prospective cohort study Eur J Intern Med 106 63-364
- [13] Hopewell JC(2021)Prioritizing the role of major lipoproteins and subfractions as risk factors for peripheral artery disease Circulation 144 353-1741
- [14] Kamstrup PR(2012)Genetic evidence that lipoprotein(a) associates with atherosclerotic stenosis rather than venous thrombosis Arterioscler Thromb Vasc Biol 32 1732-107
- [15] Tybjaerg-Hansen A(2022)Lipoprotein(a) and SARS-CoV-2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events J Intern Med 291 101-233
- [16] Steffensen R(2023)Lipoprotein(a) and coronary artery calcium in comparison with other lipid biomarkers: the multi-ethnic study of atherosclerosis J Clin Lipidol 79 223-362
- [17] Nordestgaard BG(2022)Association of Lipoprotein(a) with atherosclerotic plaque progression J Am Coll Cardiol 74 357-624
- [18] Collaboration ERF(2022)Correlation of lipoprotein (a) levels and plaque morphology in very young acute coronary syndrome patients using optical coherence tomography Indian Heart J 134 611-1734
- [19] Thanassoulis G(2016)Oxidized Phospholipids on Lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans Circulation 63 1724-347
- [20] Campbell CY(2014)Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a) J Am Coll Cardiol 12 338-1143